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Abstract
Background: In England the National Health Service (NHS) is not allowed to impose ‘blanket bans’ on treatments,
but local commissioners produce lists of ‘low value’ procedures that they will normally not fund. Breast surgery is
one example. However, evidence suggests that some breast surgery is clinically effective, with significant health
gain. National guidelines indicate the circumstances under which breast surgery should be made available on the
NHS, but there is widespread variation in their implementation.
The purpose of this study was to explore the work practices of ‘individual funding request’ (IFR) panels, as they
considered ‘one-off’ funding requests for breast surgery; examine how the notion of ‘value’ is dialogically constructed,
and how decisions about who is deserving of NHS funding and who is not are accomplished in practice.
Methods: We undertook ethnographic exploration of three IFR panels. We extracted all (22) breast surgery cases
considered by these panels from our data set and progressively focused on three case discussions, one from each
panel, covering the three main breast procedures.
We undertook a microanalysis of the talk and texts arising from these cases, within a conceptual framework of
interpretive policy analysis.
Results: Through an exploration of the symbolic artefacts (language, objects and acts) that are significant carriers of
policy meaning, we identified the ways in which IFR panels create their own ‘interpretive communities’, within which
deliberations about the funding of breast surgery are differently framed, and local decisions come to be justified. In
particular, we demonstrated how each decision was contingent on [a] the evaluative accent given to certain words,
[b] the work that documentary objects achieve in foregrounding particular concerns, and [c] the act of categorising.
Meaning was constructed dialogically through local interaction and broader socio-cultural discourses about breasts and
‘cosmetic’ surgery.
Conclusion: Despite the appeal of calls to tackle ‘unwarranted variation’ in access to low priority treatments by
ensuring uniformity of local guidelines and policies, our findings suggest that ultimately, given the contingent nature of
practice, this is likely to remain an illusory policy goal. Our findings challenge the scientistic thinking underpinning
mainstream health policy discourse.
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Background
Politicians frequently remind us that there are ‘no blan-
ket bans’ on NHS health care in England [1-3]. Despite
such assurances and the absence of national exclusion
lists [4,5], local commissioning organisationsa commonly
list procedures they will only fund if patients satisfy
particular eligibility criteria [6]. These exclusion lists
are referred to as ‘low priority lists’ or ‘procedures of
limited clinical effectiveness’ [7], terms that are used
interchangeably despite subtly different meanings.
The main arguments used to justify disinvestment
from interventions of ‘limited clinical effectiveness’ ap-
pear to follow the principles of evidence-based medicine.
For example, a report from the NHS Right Care project
(established to address variation in access to such proce-
dures) states:
“Most [commissioning organisations] have developed
policies on procedures of limited clinical effectiveness,
which include criteria to guide treatment and funding
decisions. These criteria aim to ensure the NHS
commissions interventions which are effective and
evidence based and conversely disinvests from
interventions where this is not the case” [8].
Despite the common-sense appeal of such policies, they
have prompted considerable debate in the media and be-
tween the medical profession, politicians and government.
Many of the listed procedures, such as cataract surgery, are
of proven clinical value. Critics claim that such lists are
primarily a means of reducing expenditure at a time of
financial crisis, grounding their counter-arguments in the
normative discourse of evidence-based medicine [9,10].
The NHS Right Care team report explicitly states that
‘low priority’ lists represent more than an assessment of
clinical value and that some clinically effective interven-
tions might be deemed ‘low priority’ in terms of their
claim on NHS resources [8]. Garner and Littlejohns,
reflecting on their experience at the National Institute of
Health and Clinical Excellence (NICE) conclude that:
“many suggestions for total disinvestment are based on
a ‘social judgment’ about whether it is appropriate for
the NHS to fund the intervention rather than evidence
of poor clinical or cost effectiveness” [11].
The Right Care report recommends a shift in termin-
ology away from ‘procedures of limited clinical effective-
ness [or value]’ to ‘value based commissioning’:
“Terms such as ‘procedures of limited clinical value’
have been identified as a barrier to clinical
engagement. There should be a change in terminology
to reflect a more holistic approach. ‘Value based’ or
‘effective clinical commissioning’ is proposed as a more
acceptable working title” [8].
The authors of this report do not explain why ‘value
based commissioning’ is a more acceptable term (although
the words ‘limited’ and ‘low’ have obvious negative conno-
tations), nor how it reflects a more holistic approach. The
report makes frequent reference to ‘added value’, ‘better
value’, ‘best value’ and ‘high value’ (and occasionally to
‘patients’ values’, indexing a very different meaning to the
singular form), but leaves unaddressed the fundamental
question of what is meant by ‘value’. Nevertheless, value
based commissioning is a term gaining currency in the
NHS, with commissioning organisations using it to refer
to policy guidance on treatments they will not normally
fund.
‘Cosmetic’ surgical procedures are high on the list of
treatments that NHS commissioning organisations will
not normally fund [12], and are among the commonest
requests to local ‘individual funding request’ (IFR)
panelsb, who must consider whether to fund treatment
as a special case. NHS commissioning organisations are
legally required to have a system that allows patients to
argue for a ‘low priority procedure’ or for treatment
where no policy (yet) exists [13,14] to ensure that local
commissioners are “not unreasonably restricting access
to treatment for their patients” [15]. Funding approval
rests on the IFR panel deciding a patient is an exception
to existing commissioning policies, although as Maybin
and Klein note, “there are no clear and binding guide-
lines about how ‘exceptionality’ ought to be interpreted
or what criteria should be used in decision-making” [12].
Surprisingly, there are no systematically collected, na-
tional data on IFRs, but in one locality ‘plastics’ com-
prised a quarter of all IFRs and formed the largest single
category of requests [16]. Within ‘plastics’, breast surgery
(including reduction, augmentation and gynaecomastia
correction) accounted for 47% of requests in 2008–9
and 31% in 2009–10 [16].
Breast surgery cases may be trivialised by the media
and even by professionals as ‘boob jobs’, and used as an
example of what the NHS should not spend limited re-
sources on. Headlines such as “Why did NHS pay for
this woman’s 36DD breasts but refuse to pay £24,000
for an operation so this boy can walk?” [17] not only
trivialise breast surgery, but also point to the apparent
absurdity of a decision to allocate NHS funding to it,
whilst at the same time objectifying (and with an accom-
panying picture, overtly sexualising) a woman’s breasts.
Against this background, breast surgery has become an
easy target for disinvestment [18].
However, evidence suggests that some breast surgery
offers significant health gain [19,20]. One local guideline
summarises the evidence on breast reduction surgery:
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“Two systematic reviews and numerous primary studies
conclude that breast reduction can reduce pain in
shoulders, back and neck caused by large breasts.
Patients generally express a high level of satisfaction
following surgery. Other outcomes observed in research
studies include improved psychosocial outcomes,
psychological well-being, and quality of life. One cost
effectiveness study calculated that the cost per quality-
adjusted life year (QALY) for breast reduction was in the
same range as that observed in hip replacement” [21].
This particular guideline then goes on to recommend
that:
“In the context of the resources available to provide
healthcare for their populations, [the local
commissioning organisations] consider the level of
priority assigned to provision of breast reduction as
low” [21].
At national level, the NHS Modernisation Agency (part
of the English Department of Health from 2001–5) pub-
lished guidelines for commissioners on when breast sur-
gery should be NHS funded [22]. They recommend that
female breast reduction be available if a patient is suffering
from neck ache, backache and/or intertrigo, conditional
that a professionally fitted bra has not relieved symptoms,
and the patient’s body mass index (BMI) is under 30; that
NHS surgery for gynaecomastia is allowable in post-
pubertal patients with a normal BMI, and that breast en-
largement be provided on an exceptional basis for women
with an absence of breast tissue unilaterally or bilaterally,
or with a significant degree of breast asymmetry.
A study of local implementation of these guidelines
found that they were only followed in full by 7% of local
commissioning organisations, with significant variation
between them regarding which treatments were funded,
eligibility criteria and specified thresholds. The authors
concluded that: “a ‘postcode lottery’ exists in the UK for
plastic surgery procedures, despite national guidelines” [23].
The lack of national data on IFRs means we have no
clear picture of the variation in IFR decisions about
breast surgery. In the locality quoted above, approxi-
mately a fifth of ‘plastics’ cases considered by the IFR
panel were approved for funding in 2009/10 [16]. In an-
other, none of the nine breast surgery cases considered
over a three month period was approved [24]. There is
additional variation in whether and how local commis-
sioning organisations carry out pre-panel screening
(‘triage’) of IFR referrals (undertaken by one or more
individuals and led by either administrative or clinical
staff), and the proportion of requests declined at this stage.
In the two localities quoted above, a quarter and a third of
all IFR cases triaged went to panel for review.
The wider context within which requests for NHS
funding for breast surgery are considered is one of ambi-
guity and ambivalence about its status as a health care
intervention (illustrated recently in the debate over
whether the NHS should fund the replacement of faulty
implants manufactured by Poly Implant Prothese (PIP)
[25]). The clinical specialty of plastics typically draws a
distinction between ‘reconstructive’ surgery (the correc-
tion of abnormality) and ‘cosmetic’ surgery (altering bod-
ily appearance of patients presenting “within the range
of normality”) [26]. Both are underpinned by aesthetic
principles addressing bodily form and function, and
mental and physical health. However, critics point out
that the boundary between ‘normal’ and ‘abnormal’ is
always contested, and that distinctions between recon-
structive and cosmetic, form and function, psychological
and physical are “dubious and misleading, given their in-
herent interconnectedness” [27]. Nonetheless, as Naugler
points out, these definitions and distinctions “have im-
portant ramifications for the acceptance, accessibility
and personal meanings of specific plastic surgery proce-
dures” [27]. Other researchers have explored ‘cosmetic’
surgery’s precarious status between ‘beauty practice’, an
‘expression of identity’, and medical intervention in
socio-cultural discourse [28,29]. More prosaically, the
word ‘cosmetic’ in everyday language is often used to con-
vey superficiality, something “without any real substance”
(Chambers English Dictionary).
Against this backdrop, our research explores how deci-
sions about IFR breast surgery cases are made in prac-
tice. Studying deliberation illuminates how the notion of
‘value’ is dialogically constructed, and how ‘value’ judge-
ments are made about who is deserving of NHS funding
and who is not. Exploring how ‘deservingness’ is con-
structed in relation to health care becomes particu-
larly salient at times of increasing pressure on NHS
resources [30]. Although some researchers have ex-
plored ‘social values’ in health care rationing [31,32],
values are usually treated as pre-defined, fixed entities
(for example ‘process’ values of transparency, account-
ability and participation, and ‘content’ values such as
equity, solidarity and autonomy), that act as an ‘objective’
checklist to decision-making, rather than as contested,
emergent and situated phenomena [33]. Our analysis
aligns with those who view the process of ascribing value
as an interpretive act involving ethical-moral choices,
constructed moment-by-moment by social actors through
interaction [34]. We take a practice-based view of deliber-
ation, in which social life is explored as an “ongoing
production” and decision-making a “dynamic accomplish-
ment rather than a static outcome” [35].
Our research aims to illuminate how variation in
health care (the ‘postcode lottery’) is produced locally
through micro-rationing practices. Much of the research
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on health care variation explores this at a macro level
of statistical analysis, seeking clues as to how to reduce
‘unwarranted variation’ [36]. But the question of how
variation is constituted locally and how this intersects
with the notion of value based commissioning remains
unaddressed.
Methods
The data presented here were part of a larger study
of the rationing practices of IFR panels. The research
received ethical approval from UCL Research Ethics
Committee (ref: 0363/004), covering all sites involved.
We undertook in-depth ethnographic exploration of the
work practices of three IFR panels over a three-year
period. Panels varied in their composition but typically
included staff from the local commissioning organisation
(directors of public health, nursing, finance and commis-
sioning); a local general practitioner, pharmacist, and, in
one site, a lay representative. In one locality (site A),
nearly all panel discussions took place by email and we
collected several thousand email exchanges; in the sec-
ond site we audio-recorded one IFR panel discussion at
which seven cases were discussed (site B); and in the
third site we observed and took detailed field notes of
five panel meetings covering a total of 15 cases (site C).
In all three sites we interviewed panel members and
collected associated documentation (evidence reviews,
correspondence with referring clinicians and patients).
Written informed consent was obtained from research
participants. Our data set included 19 discussions (by
email) about breast surgery in site A, one in site B and
two in site C. For the purposes of the research presented
in this paper, we initially looked at all 22 cases and then
progressively focused in-depth on three case discussions,
one from each study site, covering the three main breast
procedures.
We drew on Yanow’s conceptual framework for inter-
pretive policy analysis to analyse the enactment of low
priority treatment policies on breast surgery. The role
of the interpretivist policy analyst is to uncover the
‘architecture of policy arguments’ and how a policy
means [37]. Yanow identifies three categories of ‘symbolic
artefacts’ as significant carriers of meaning: language, policy
objects and acts. We explored [a] the language used by
actors in panel discussions and minutes of their meet-
ings; [b] policy objects such as guidelines and policy
statements, referral letters from clinicians, patient rep-
resentations, and legal judgements; and [c] the act of
categorisation.
For each of the selected cases, the three authors en-
gaged in independent close readings of data transcripts,
field notes, and policy guidance, and then in joint ana-
lysis sessions, exploring the meanings conveyed through
language, objects and acts. We brought to our analysis a
range of sensitising concepts from linguistic ethnography
[38]. Firstly, the contribution of Bakhtin on the evalu-
ative nature of language and the concept of ‘voice’ as
‘speaking consciousness’ in which particular values or
viewpoints are enacted [39]. For Bakhtin, language is al-
ways a site of social struggle; it is not a neutral linguistic
resource, but is “already ‘overpopulated’ with other peo-
ple’s voices and the social practices and contexts they
invoke” [39]. Every time we speak, we assimilate and ap-
propriate the words of others and populate them with
our own meaning, our own ‘evaluative accent’ in what
Bakhtin refers to as the “ideological becoming of a hu-
man being” [39].
Secondly, our analysis was sensitised by theoretical
work on the micro-level practices of categorisation in in-
stitutions [40,41]. For example, institutional categories
are invoked as ‘fixed entities’ to help organise and
process people through institutions and often reveal
what is taken for granted as common sense. At the same
time categories are contested and discursively consti-
tuted in deliberation as participants oscillate between
generalisation and particularisation of a case [42].
Results and discussion
We begin this section with a summary of the three cases
selected for in-depth analysis. Some details have been
fictionalised to ensure anonymity and the names given to
patients are pseudonyms. The first case is a referral of a
14 year-old boy (Jack) suffering from bilateral gynaeco-
mastia. The local commissioning organisation has received
letters from Jack’s GP and a specialist breast surgeon:
“It was a pleasure to review this extremely bright
young man in clinic today along with his father.
Jack has been suffering from bilateral gynaecomastia
from the age of seven, which has been gradually and
progressively enlarging in size. His father had similar
problems as a young man. This cosmetic impediment
is causing Jack significant psychological stress and he
finds it extremely embarrassing to undress in front of
his peers. He is otherwise physically well developed
with secondary sexual characteristics consistent with
his age and has a slim frame.
[…]
Given the volume of his gynaecomastia he would most
certainly require re-position of his nipple areola re-
gardless of whatever kind of surgery he has. There may
be some merit in combining liposuction with a more
definitive procedure later on to positively influence the
eventual cosmetic. Despite his age surgery could be of-
fered to him as the problem is quite clearly present
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and appears to be largely fatty, incompatible with his
physical frame.” [Extract from the breast surgeon’s re-
ferral letter to the IFR panel]
The case is discussed by email over several weeks, by
a panel of commissioning managers, both clinical and
non-clinical (see Table 1). After an initial delay in the
case being reviewed, a telephone call from the patient’s
father indicating that his “son is being bullied at school
because of his condition and so the dad is obviously irate
and would like some information” (email from IFR ad-
ministrator to panel), prompts consideration of the case.
The ensuing discussion between panel members focuses
on attempts to categorise the case in terms of the
commissioning organisation’s funding mechanisms and
whether or not the procedure is considered cosmetic. A
decision is taken not to fund.
The second case concerns a 48 year-old woman (Brenda)
whose request was identified on the IFR summary form as
“plastics for breast asymmetry”. The patient has a heart
condition that required her to have a device fitted in her
chest some years ago. When this was fitted she also had
bilateral breast augmentation to camouflage the device.
Complications resulted in the removal of one breast im-
plant, causing breast asymmetry. The case was initially
turned down at triage, but after letters of complaint from
the patient’s MP [Member of Parliament] and a private
plastic surgeon, was referred to the IFR panel. The panel
meets monthly, and is unusual in that patients are offered
the option of giving a 10 minute representation of their re-
quest, although in this case the patient had chosen not to
attend. The panel discussion focused on whether Brenda
could be defined as ‘exceptional’ or not. After a lengthy dis-
cussion the decision was that Brenda was not exceptional
and her request declined.
We reproduce an extract from research ethnographic
field notes from observation of an IFR panel meeting in
site C in which Brenda’s case of breast augmentation
was discussed.
“The IFR request was made in September 2011 by the
patient’s hospital consultant where the original treatment
occurred. It stated:
‘The patient’s quality of life would be greatly impacted
upon [if the treatment was not approved]. The patient
Table 1 Extract from IFR panel email discussion about Jack’s case of gynaecomastia (site A)
From To Email text
Asst Director Public Health Commissioning Manager Please circulate my view, thanks. We would normally refuse to fund this as it’s a
cosmetic procedure, however we need to be sure about the following points:
• significant adverse effect on activities of daily living
• significant disfigurement and I think should request further information on these,
in particular the first one. I also think we should seek the [Assistant Director of
Children’s Commissioning] views since this request is for a 14 year old child.
Chair of IFR Panel Director of Commissioning cc Panel Could you have a look at this, please. I’m not sure that it’s a contract exclusion
and I wonder if it should be covered by PbR [Payment by Results].
Breast reduction is normally something done to women with big breasts. The
patient here is a young male with an unusual condition called gynaecomastia.
This usually occurring in early adolescence and is a potential exception under
the sector’s low priority treatments policy.
If this were a contract exclusion then I’d say we could not fund it at present on
affordability grounds, but I wonder if it could be classified as something under
PbR and would not be considered to be a contract exclusion?
Happy to discuss further.
Director of Commissioning Chair of IFR Panel; cc Panel I do not believe it is covered under PbR. I can find no reference to this under
PbR. The consultant has also mentioned in his letter that it is cosmetic. We also
have to bear in mind if [NHS hospital trust] carried out a procedure on a child
they could apply a 78% uplift for the procedure from the adult tariff.
Chair of IFR Panel Director of Commissioning; cc Panel Thanks. If the consultant says that this is cosmetic and it’s not covered under
PbR then we must decline to fund this on affordability grounds and because
of the low priorities treatment policy (noting that gynaecomastia is a potential
exceptional circumstance in this policy).
Assnt Dir. of Finance Panel I consider this cosmetic and therefore suggest that we do not fund this.
Director of Nursing Panel Although I appreciate that this is very problematic for the individual this particular
request is as outlined by the consultant surgery for cosmetic reasons therefore I
suggest that we do not fund this particular request.
Public health specialist Panel I agree not to fund this procedure for cosmetic reasons.
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is currently on anti depressants and does not feel
comfortable to leave the house or have a sexual
relationship with her partner as she will not allow
herself to be seen undressed. The patient has a long
history of [mental health condition], having the
surgery could avoid any further deterioration in the
patient’s mental health’.
The request was turned down at triage one month later.
The decision letter contained the following statement:
‘The XXX Referral and Treatment Criteria, state that
breast augmentation/revision of breast implant
procedures are not routinely funded [and]
… psychological/psychiatric morbidity is not a criteria
for funding aesthetic procedures. The IFR cannot take
into account social, personal or emotional issues as we
can only make decisions based on health needs.
Therefore, while sympathetic to the fact that your
patient may be disappointed, in accordance with IFR
Policy, this application will not proceed to the IFR
Panel and funding will not be provided’.
The agenda papers indicated that this decision letter
prompted the patient to involve her MP. The PCT cus-
tomer services officer wrote to the chair of the IFR panel,
stating:
‘The MP has written on her behalf seeking to have a
positive impact on the IFR team’s decision. In line
with the NHS Complaints Procedure, I would be
grateful if you could help me respond to his enquiry
and either reconsider the decision or provide me with
a more detailed explanation of the reason why her
request for the re-insertion of the breast implant has
been denied’.
The documentation also included a letter from a private
plastic surgeon whom the patient consulted, stating that the
patient is:
‘at her wits end due to the cessation of her NHS
treatment at the end of last year”. … “My feeling as a
plastic surgeon both privately and during the NHS full
time is that she should have this done as she now has
gross breast asymmetry which makes garment wearing
problematic. Therefore there is a functional as well as
a psychological benefit to this operation. She was also
halfway through her treatment that was allowed on
the NHS up until the middle of last year and I think it
is unfair that it was stopped before finalisation. In
addition, her heart condition means that surgery
elsewhere is prohibitively dangerous as she needs
cardiology and cardiothoracics to be present as well as
a cardiac anaesthetist. This means I cannot do the
surgery for her here. I think [the hospital] would be the
most appropriate place for her to have this re-insertion
of an implant’.
The Chair (Director of Nursing) summarised the above
case history, noting the patient’s high anaesthetic risk.
She asked the panel if they thought this patient was ex-
ceptional? The Director of Commissioning said that he
didn’t see the patient as exceptional, although the cir-
cumstances leading to the request ARE exceptional, what
she’s asking to have done ISN’T.
[…]
The public health consultant said that from the
panel’s viewpoint they’re most concerned about the
FUNCTIONAL benefits of a procedure. He quoted
from the private consultant’s letter:
‘garment wearing [is] problematic. Therefore there is a
functional as well a psychological benefit….’
There was agreement that this is not functional benefit
in the sense that the panel defines it. The chair said that
functional benefit has to be clinical benefit.
The GP member then commented:
‘it’s a difficult one, how do we rationalise patients
having implants after breast cancer surgery [the policy
explicitly says it does not apply to patients undergoing
breast reconstruction as part of treatment for breast
cancer] but not for an infection such as this? [the
implant had apparently originally been removed
because of an infection and complications]. “There’s a
bit of me saying what’s the difference?’
[….]
The pharmacist suggested that the IFR request ‘boils
down to an application for making someone symmetric
who is asymmetric, so at the end of the day it’s a cos-
metic procedure’.
The Director of Commissioning (who at the start had
said he did not believe the patient was exceptional)
seemed to agree with the GP that ‘if we do it for cancer
patients then perhaps we should do it for this patient
who genuinely needed the operation to have the [device]
in the first place’.
At this point the panel were struggling and fumbling,
clearly not at all sure where to take the discussion next.
The GP, an authoritative member of the panel, had
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made a strong case for this patient to be treated as
exceptional in the same way as the policy treats can-
cer patients as exceptional. At the same time, the re-
ferring clinician had not made a strong case for
clinical benefit (within the narrow definition of clin-
ical benefit being used by the panel) and there was a
sense in which this was ‘at the end of the day’ cos-
metic surgery, which the policy clearly says the PCT
won’t pay for.
The GP repeated his views about personally not seeing
the difference between this patient and cancer patients.
The Director of Commissioning agreed with him, saying
his view was the same as the GP’s.
[… ]
The Director of Commissioning (trying to bring the
panel to some decision I sensed) said I don’t think this
meets exceptionality in the broadest sense (now returning
to his starting position). The chair asked each panel
member what they thought:
Pharmacist – ‘not exceptional’
Lay member – ‘not exceptional’
Chair – ‘not exceptional’
GP – ‘I think it is’.
Chair – ‘I’m sorry GP you’re outnumbered on this one.
Is that OK?’
GP – ‘Yes, it’s OK’.
The third case concerns a 38 year-old woman, Jane
(see Table 2). Her GP reports that she is suffering from
backache due to her large breasts and that “the patient
states physiotherapy and analgesia have not helped”.
The documents considered include a letter from the pa-
tient to her GP putting forward her case for surgery, and
a report from the local physiotherapy department, not-
ing that the patient responded “partially to the rehabili-
tation program and has been discharged”. The case is
considered by a panel that meet weekly. They discuss
the details of the physiotherapist’s report and patient’s
letter and reach agreement that the case is exceptional
and funding is approved subject to confirmation of the
patient’s BMI.
Below, we present a micro-analysis of these cases to
show how, through the artefacts of symbolic language,
objects and acts, meaning is constructed and commu-
nicated, and IFR panels create their own ‘interpretive
communities’ within which local decisions are justi-
fied. For the purpose of this analysis we put to the
background the different modes of communication
(email, face-to-face); panel composition (for example the
inclusion of lay representatives), and the particular local
financial contexts. A more in-depth account of these and
other aspects of IFR decision-making can be found else-
where [43-45].
Symbolic language
A notable feature of the presentation and discussion
of Jack’s case is the evaluative function of the word
‘cosmetic’. According to Bakhtin, all language is inher-
ently evaluative and passes judgement on the world as it
describes it [39]. In the referral letter, the consultant
builds up a strong case of exceptionality (in line with
the requirements of IFR decision-making as described
above), referring to the boy’s “suffering”, “significant
psychological distress”, “extremely embarrassing”, “the
volume of his gynaecomastia”, all phrases that empha-
sise the validity of his exceptional status. Within the
context of this description of ‘exceptionality’, the ref-
erence to the “cosmetic impediment” arguably empha-
sises the impediment rather than its ‘cosmetic’ nature.
The dissonance between the two words is striking: an
impediment is not merely ‘cosmetic’. The consultant
describes his treatment plan “to positively influence
the eventual cosmetic”; the word ‘cosmetic’ here sug-
gests a medical textbook meaning, i.e. surgery altering
the appearance of the body.
However, in the email discussion the panel gives a
very different evaluative accent to the word cosmetic.
Here ‘cosmetic’ references a category of treatment in
their low priority treatment policy that they “normally
refuse to fund”. By labelling the request ‘cosmetic’, the
panel indexes a common sense institutional classifica-
tion system that, in the words of Mary Douglas “de-
scribes the way things are” [41], and the request easily
loses its entitlement to funding. Moreover, at the same
time as panel members give the word a new evaluative
accent, they appropriate the surgeon’s voice, saying
“The consultant has also mentioned in his letter that it
is cosmetic”, and “If the consultant says that this is
cosmetic… then we must decline to fund…”. In other
words, they attribute their (the panel’s) evaluative ac-
cent to the surgeon’s voice, introducing ‘attributional
distance’ [46] between themselves and their decision
not to fund.
This example shows how the different evaluative ac-
cent of a single word functions to override the consider-
able work the consultant does to build a case for
funding. Following Bakhtin, we suggest that the evalu-
ative accent the panel gives to the word ‘cosmetic’ is not
only a reflection of the here-and-now of policy dis-
course, but also contains echoes of “historical and cul-
tural scripts” [42], invoking societal views of cosmetic
surgery more as ‘beauty practice’ than ‘medical inter-
vention’ [28], and thus as something inherently undeserv-
ing of NHS funds.
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The data extracts contain other instances of the evalu-
ative accenting assigned to specific words and phrases.
The word ‘functional’ for example, acquires a number
of meanings in relation to breasts. The breast func-
tions as an organ of lactation and a secondary sexual
characteristic as well as (pathologically) interfering with
the functions of other organs and structures (e.g. the
pectoral muscles and thoracic spine). As a surface
structure, it also functions more symbolically as part
of a healthy body contour and plays a significant role
in gender identity.
In Brenda’s case, the consultant makes a case that “there
is a functional as well as psychological benefit to this
operation” because “she [the patient] now has gross breast
asymmetry which makes garment wearing problematic” – a
comment that explicitly emphasises the breast’s abnormal
biomechanical function while also acknowledging its sym-
bolic one in shaping body image and identity. However, the
panel fails to engage with this definition of ‘functional’, stat-
ing that functional benefit has to be “clinical benefit”.
In fact, although significant functional impairment
(and the potential to reverse it) is sometimes identified as
Table 2 Extract from transcript of audio-recording of IFR panel meeting about Jane’s case of breast reduction (site B)
Speaker Spoken words
Chair Moving on to this case which is breast reduction, for back ache, we haven’t really… (inaudible)
CPH How old is she? (pause whilst members look through papers including a report from a physiotherapist and a letter from the patient
in support of her application)
ADPH The physio report, doesn’t actually recommend, or what it says is that patient has responded partially [to
Chair partially]
ADPH the rehab programme and has been discharged.
Chair mmm
ADPH she needs a good bra
GP I mean I think her letter actually says very much more [than
ADPH yes] exactly
GP anything, now it’s a question of whether, you know, she’s not had a relationship, she feels embarrassed, there’s obviously
a psychological=
ADPH hardly (inaudible) 38DD=
GP =well if she is 4 foot 11 and quite a petite [frame
ADPH what’s her] BMI?
GP then that could well be large. And the fact that she has had three children will make them much more pendulous anyway so I
could accept that she says they hang to her stomach and all the rest of it.
Chair: I think the main thing here is that she hasn’t been referred, she doesn’t appear to have been referred to an orthopedic surgeon [or
GP breast] reduction, well
Chair to get a second clinical opinion. We’ve got the GP’s opinion but she hasn’t had any MRIs or anything like that. We don’t know what
the other potential factors could be.
GP I don’t know that an MRI would help to be honest. I think there are much more psychological issues with this lady than (.) the
backache is to be honest neither here nor there. I am actually more concerned about the fact that she is withdrawing, she can’t
pick up her child, she feels embarrassed to have an intimate relationship, umm
ADPH She’s got a very young child, a 2 year old
GP She’s got very young children, and I think [that’s
ADPH yeah]
GP that’s making her exceptional personally and I would say, I would approve then
Pharmacist (inaudible)
GP I mean the only thing I could check is what her BMI is=
ADPH =I think that’s the only thing I wanted
GP whether there is a, you know, if she was a BMI of 40 then maybe losing=
Pharmacist weight
GP weight would actually make them less heavy but she might still need a procedure to make [them
ADPH I think] in principle we would agree but I mean I also want to know what her BMI is though
GP = general practitioner. ADPH = Assistant Director of Public Health. CPH = Consultant in Public Health.
Transcribing conventions: = no pause between speakers; [ onset of overlapping speech; ] end of overlapping talk.
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a relevant criterion for breast reduction, we found no
guidelines referring to it for breast augmentation (for ex-
ample to correct gross asymmetry). For breast reduction
surgery, some commissioning organisations specified
what they meant by significant functional impairment,
but there was no consistency across organisations. In one
locality, for example, the emphasis was on social func-
tion: “Symptoms prevent the patient fulfilling vital work
or educational responsibilities, or symptoms prevent the
patient carrying out vital domestic or carer activities”.
More commonly (as in Jane’s case below), guidelines
defined functional impairment in terms of physical func-
tion, such as back or shoulder pain.
These examples of symbolic language illustrate how, in
making their case for funding, doctors use particular
words, either because they are part of their everyday
medical lexicon, or perhaps because they are aware of
the rules which govern funding policies. However, each
locality has different rules (and doctors may deal with
several commissioning organisations), and the rules
are differently drawn upon and interpreted within IFR
panel deliberations. Each decision is therefore contin-
gent on how words come to acquire specific meanings
in practice.
Symbolic objects
Taking Yanow’s second category of policy artefacts, we
explore the role of documents as symbolic objects carry-
ing meaning. A significant proportion of IFR panel activ-
ity involves interpreting and making sense of cases
through considering documents - policy guidelines, re-
ferral letters, patient letters, and so on. Typically, a col-
lection of papers relating to each case is circulated to
panel members before the meeting (or as part of an
email discussion). At the discussions we observed mem-
bers spent time shuffling papers, looking back and forth
between papers, and reading aloud from documents to
draw the panel’s attention to specific extracts. As previ-
ous research has shown, documents formed a critical
part of the groups’ sense-making activities, comprising
“articulating, debating and validating different readings”
of documents [47], as they created a shared narrative of
the case [48]. In this section we explore the work that
documents achieve in foregrounding particular concerns.
Specifically, we explore how documents inscribe both in-
stitutional and patient framings of a funding request,
creating a ‘dilemma of attention’ for panel members, as
they struggle to attend to the patient’s concerns on the
one hand and institutional concerns on the other [49].
In Jack’s case, the consultant’s referral letter empha-
sised the psychological aspects of the patient’s condition
(although these were not discussed by the panel). Across
our dataset we noted that this emphasis on psychological
factors was common in referral letters for breast surgery.
We also noted the following patient information on the
NHS Choices website: “Cosmetic surgery is rarely avail-
able through the NHS. There must be a major physical
or psychological reason for needing the surgery”. We
might assume that this guidance encourages patients
and their doctors to emphasise psychological factors in
arguing their case.
However, in Brenda’s case, reference to psychological
morbidity becomes a reason for refusing a funding re-
quest for funding. The initial ‘triage stage’ decision letter,
in which the patient’s doctor is informed that “this appli-
cation will not proceed to the IFR panel and funding will
not be provided”, quotes from the local policy document,
stating that “psychological/psychiatric morbidity is not a
criteria for funding aesthetic procedures” (incidentally, a
clause that was added to the 2011 version of the policy
document). The decision letter goes on to say: “the IFR
cannot take into account social, personal or emotional
issues as we can only make decisions based on health
needs”. This latter sentence refers to a widely cited but
erroneous interpretation of case law, which we have dis-
cussed previously [44]. As we set out in that paper, a
number of recent legal judgements have confirmed that
when considering IFR cases, commissioning organisa-
tions do not have to take account of ‘social factors’ in
their assessment of exceptional circumstances, but this
legal position is frequently interpreted, as here, as mean-
ing that they cannot take social factors into account.
The overall effect of the decision letter containing these
policy quotes is to suggest that reference to psycho-
logical factors in the request ‘ruled out’ its consider-
ation as an IFR, and furthermore, the suggestion is
that psychological morbidity, however profound, is not
a ‘health need’.
This example shows how the local policy document is
crucial in defining meaning. Reference to it serves to
emphasise an institutional framing of the IFR and re-
move the need for deliberating the merits of the specific
case at a panel meeting; it becomes a more or less
straightforward case of ‘the policy says no’. In our in-
terviews with panel members, respondents expressed
concern about the increasingly significant role of pre-
panel triage in the IFR process. They suggested that
important perspectives (those of the patient, GP, or lay
representative), widely recognised as essential to fair
deliberation of complex cases [50,51], are being mar-
ginalised from IFR decision-making, and superseded
by an algorithmic, technocratic approach to potentially
‘exceptional’ cases, which by their very definition,
should not be judged against a set of rules.
Policy guidance is only one type of IFR documenta-
tion. Additionally, there are referral and advocacy letters
setting out the patient’s case, and whether, how and to
what extent these are brought into and able to influence
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discussions. In Brenda’s case, after the initial rejection of
the IFR at triage, letters from the patient’s MP and a pri-
vate plastic surgeon bring further authoritative voices to
the table and prompt consideration of Brenda’s case
by the IFR panel, making it possible that the patient’s
framing of the case can take a hold (see next section).
However, ultimately it is the institutional framing of ex-
ceptionality that dominates discussion and leads to a de-
cision not to fund. Similarly, in Jack’s case the patient’s
voice is conveyed through the consultant’s referral letter
and a phone call from the father, but in the ensuing
email discussion it quickly evaporates and attention fo-
cuses on institutional concerns.
By contrast, in Jane’s case the patient’s voice is success-
fully privileged over the words in the policy documents
by the GP framing the discussion in the patient’s terms
early on. The GP responds to another member who is
summarising the physiotherapist’s report, saying “I think
[the patient’s] letter actually says very much more than
anything…”. The patient’s condition and circumstances
quickly become the focus of attention, with the GP ani-
mating the patient’s own words (“she can’t pick up
her child, she feels embarrassed to have an intimate
relationship…”) [52]. The rhetorical work of the GP’s
contribution is apparent: she highlights the patient’s role
as a mother of three children, and she prefaces her anima-
tion of the patient’s words by emphasising her concerns
about “the fact that [the patient] is withdrawing”, adding
her professional legitimacy to the patient’s voice.
Interestingly, in Jane’s case, far from being a reason
NOT to fund, psychological morbidity is the explicit rea-
son for the panel to fund the request. Even though the
local policy states that: “Funding should be considered if
there are clear physical problems e.g. serious functional
impairment, significant neck/back pain, intertrigo AND
BMI < 30”, the GP argues that “there are much more psy-
chological issues with this lady than.., the backache is to
be honest neither here nor there”, and successfully per-
suades the panel to agree in principle to fund Jane (once
she has checked Jane’s BMI with her GP).
Again, our analysis of how these artefacts are drawn
upon in the discussion highlights how highly contingent
the course of deliberation and decision-making can be.
Which particular phrases or words from a policy are
quoted, how they are interpreted, the different ‘voices’, in
the Bakhtinian sense, that are present and brought into
and frame discussion, all contribute to how panels create
their own specific interpretation and narrative of the
case, that leads them to a decision to fund or not.
A striking feature of all three cases was the absence of
certain documents from discussion. Whereas a charac-
teristic of many IFR cases was the sizeable amount of
research evidence (literature reviews and/or original re-
search papers) included as background documentation
and brought into discussion, with breast surgery cases
there was a surprising lack of reference to formal evi-
dence. This contributes to the sense that breast cases
were not taken as seriously as some other requests and
did not warrant the attention to scientific research. This
was also reflected in some of the ‘common sense’ as-
sumptions made about these requests. For example, our
field notes record the chair of an IFR panel introducing
one case to the panel with the comment “Today’s breast
augmentation! Do we ever have a week when we don’t
have one!”, and another IFR panel member commenting
in an interview that “with the beauty interventions, we
know to decline them, … we don’t really think about it”.
Arguably, these comments reflect and reproduce deeply
ingrained cultural views about the triviality and even
comical nature of breasts and cosmetic surgery, what we
might refer to as the ‘boob-job’ perspective.
Symbolic acts
Yanow’s third category of artefacts are ‘symbolic acts’.
Here we focus on the act of categorising, as part of the
process of deciding what to fund. Categorising is a fun-
damental part of institutional work, it legitimates what
institutions do by describing the way things are in the
social world [41,53], it enables institutions to ‘sort things
out’ [54], and makes possible the people-processing ac-
tivities in which institutions are engaged [42]. Crucially,
these authors emphasise the act of categorising as in-
volving moral evaluation; in the case of IFRs, deciding
whether a patient is deserving of NHS funds.
Individual funding requests involve an enormous
amount of categorising – panel members deliberate
about whether a patient’s case fits the IFR category
or not, fits the category of exceptionality or not, is
about psychological morbidity or not, and so on. The act
of categorising may be quite obvious, or it may be more
subtle and concealed. In Jack’s case, for example, the
chair of the panel comments:
“Breast reduction is normally something done to
women with big breasts. The patient here is a young
male with an unusual condition called gynaecomastia.
This usually occurring [sic] in early adolescence and is
a potential exception under the sector’s low priority
treatments policy.”
This statement not only places Jack in a diagnostic cat-
egory that is a “potential exception” under local policy,
but also serves to set apart the category of “women with
big breasts” applying for breast reduction from those
with the “unusual condition” of gynaecomastia, empha-
sising the exceptionality (and arguably deservingness)
of (young) male cases of breast surgery. In the end,
however, as we argued above, the labeling of Jack’s
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request as ‘cosmetic’ trumps all other arguments, and his
‘exceptionality’ fails.
In Brenda’s case the GP on the panel questions the
categorisation of patients as set out in local policy. He
says that he cannot really see the difference between pa-
tients having implants after breast cancer surgery (which
the NHS automatically funds) and this patient who is
requesting re-insertion of an implant after clinical com-
plications related to her heart condition. But later in the
discussion, the community pharmacist member suggests
that “the request boils down to an application for making
someone symmetric who is asymmetric, so at the end of
the day it’s a cosmetic procedure”, and eventually, after
considerable discussion, the GP is outvoted and the re-
quest refused.
The pharmacist’s intervention is an example of what
scholars of rhetoric refer to as argument by association
[55]. By dissociating asymmetry from the ‘deserving’
category of cancer patients, and associating it with
the implicitly-agreed-to-be ‘undeserving’ category of a
‘cosmetic procedure’, ‘boiling down’ the case to one of
asymmetry, the request easily fits the organisation’s pol-
icy not to fund (breast augmentation “is not routinely
funded within the local NHS for any patient group”).
Incidentally, a year earlier, the local policy did permit
breast augmentation for gross asymmetry. The basis for
this change in policy wording is unclear, especially given
national guidelines stating that “exception should be
made for women with a significant degree of asymmetry
of breast shape and/or volume” [22].
Conclusion
Current health policy debates emphasise the need to
tackle ‘unwarranted variation’ in access to NHS treat-
ments, including those on ‘low priority’ lists, by ensuring
uniformity of local guidelines and policies [6,12]. Such
recommendations have an intuitive appeal. It is un-
doubtedly difficult to understand why in one locality
breast augmentation may be eligible for NHS funding to
correct asymmetry if “there is a disparity of 2 or more
cup sizes in the lower range (size C or below) or 3 or
more cup sizes in the upper ranges (size D upwards)”,
but in another locality the same procedure is ineligible
for NHS funding for any patient group. Or why in
one locality “significant psychological problems due to
poor body image” is permissible as an exceptional cir-
cumstance for breast reduction surgery, whereas in another
locality “psychological morbidity is not a criterion”
for funding it. Such ‘unwarranted variation’ lends
strong support to the recent recommendation from
the British Medical Association that commissioning orga-
nisations should collaborate to ensure consistent pol-
icies across localities, with greater reference to national
guidelines [6].
However, our findings suggest that ultimately the
search for uniformity is likely to be an illusory policy
goal. There exists a fundamental paradox at the heart of
the IFR system for rationing health care resources. On
the one hand it is a system predicated on and requiring
case-based reasoning and judgement, to ensure that
funding decisions are based upon individual patient cir-
cumstances [15]. On the other, it is a system that has
evolved to become increasingly formalised and bureau-
cratised, with more and more emphasis on the use of
pre-defined rules (eligibility criteria, attempts to define
exceptionality, treatment thresholds, and so on). In our
study we observed a discernible tension for panel mem-
bers between framing cases as complex instances of
human suffering, involving moral engagement and emo-
tionally and clinically challenging judgements, and in-
stances of technocratic processing, involving instrumental
negotiations over policy fit.
The turn to technocratic and rule-based reasoning is
understandable in that it makes manageable the difficult
tasks of rationing health care and critically appraising
the clinical judgement of referring clinicians. The privil-
eging of ‘system’ rules allows panel members to sidestep
the fundamental ethical choices at the heart of IFR cases.
But – and this is the real illusion of a standards based
reasoning approach – rules must always be interpreted
[56]. Our findings suggest that, even if greater uniform-
ity of local policies were achieved, each local decision-
making group will still create their own interpretive
community within which local decisions will be justified.
The subtleties of social interaction ensure that a puta-
tively ‘rational’ system for decision-making remains a
largely idiosyncratic one.
What are we to make of the shift in terminology from
referring to procedures such as breast surgery as ‘low
priority treatments’ or ‘procedures of limited clinical ef-
fectiveness’ to ‘value based commissioning’? Certainly
this sort of linguistic work invokes a more positive
image; it would be hard to disagree with the notion of
commissioning being based on some sort of value. And
the similarity of the term with ‘values based commis-
sioning’, which explicitly privileges patient defined needs
and values in the commissioning of mental health ser-
vices [57], is perhaps not coincidental. The problem,
however, is that accounts of value based commissioning
present ‘value’ as an incontrovertible ‘fact’ that requires
no further explanation, and can even be measured and
audited [8]. In contrast, we have demonstrated how, in
relation to individual cases, value is essentially indeter-
minate and uniquely constituted in situated contexts
through dialogical reasoning. Despite the rhetoric of
value based commissioning, and the evidence of clinical
benefit of some breast surgery, our study indicates that
breast surgery’s precarious status as a legitimate health
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care intervention in the NHS to alleviate pain and suffer-
ing is likely to remain.
The implications of our findings extend beyond breast
surgery and IFRs in the NHS. By looking at instances
of decision-making close up, we have illuminated how
health care rationing policy and practices, as interpretive
acts, inevitably involve judgements of moral worth and
deservingness, and can never be simply evidence-based
endeavours. In this sense, our findings contribute to a
growing body of research [58-62] that fundamentally
challenges the scientistic thinking [34] underpinning main-
stream health policy discourse.
Endnotes
aNHS commissioning organisations are responsible for
commissioning health services for their local population.
They control around two thirds of the NHS budget. At
the time of this study 152 ‘primary care trusts’ (PCTs)
commissioned local health services in England; in April
2013 PCTs were replaced with approximately 200 clinical
commissioning groups (CCGs).
bCommissioning organisations delegate decisions on
requests from patients and their doctors to fund a par-
ticular test or treatment as a ‘one-off ’, even though the
NHS (at least in that locality) does not normally fund
it to ‘individual funding request’ (IFR) panels. Panels
vary in their composition from locality to locality but
typically include commissioning organisation staff (e.g.
directors of public health, finance, nursing), local gen-
eral practitioner(s), a pharmacist, and sometimes lay
representatives.
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